CVRx (CVRX) Change in Receivables (2020 - 2026)
CVRx's quarterly Change in Receivables came in at -$1.6 million in Q1 2026, down 509.77% year-on-year from $380949.5 in Q1 2025, and down 163.56% quarter-over-quarter from $2.5 million in Q4 2025.
CVRx has reported Change in Receivables for 7 years, with the latest figure at -$1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 509.77% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at $92000.0 (down 82.21% YoY), and the FY2025 full-year result was $1.4 million, down 18.64% from the prior year.
- Change in Receivables for Q1 2026 stood at -$1.6 million, down from $2.5 million in the prior quarter.
- The five-year high for Change in Receivables was $2.5 million in Q4 2025, with the low at -$1.9 million in Q2 2025.
- Average Change in Receivables over 5 years is $384941.2, with a median of $292000.0 recorded in 2023.
- Peak annual rise in Change in Receivables reached 945.11% in 2025, while the deepest fall reached 1774.77% in 2025.
- Tracing CVRX's Change in Receivables over 5 years: stood at $207000.0 in 2022, then surged by 469.57% to $1.2 million in 2023, then plunged by 80.07% to $235000.0 in 2024, then soared by 945.11% to $2.5 million in 2025, then sank by 163.56% to -$1.6 million in 2026.
- The last three Change in Receivables figures came in at -$1.6 million (Q1 2026), $2.5 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn | -1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.56 Mn |
| Mar 31, 2026 | -1.56 Mn |
| Dec 31, 2025 | 2.46 Mn |
| Dec 31, 2025 | 2.46 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | -1.86 Mn |
| Mar 31, 2025 | -256,000.00 |
| Mar 31, 2025 | -256,000.00 |
| Dec 31, 2024 | 235,000.00 |
| Dec 31, 2024 | 235,000.00 |
| Sep 30, 2024 | 427,000.00 |
| Sep 30, 2024 | 427,000.00 |
| Jun 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 111,000.00 |
| Mar 31, 2024 | 944,000.00 |
| Mar 31, 2024 | 944,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | -354,000.00 |
| Sep 30, 2023 | -354,000.00 |
| Jun 30, 2023 | 292,000.00 |
| Jun 30, 2023 | 292,000.00 |
| Mar 31, 2023 | 930,000.00 |
| Mar 31, 2023 | 930,000.00 |
| Dec 31, 2022 | 207,000.00 |
| Dec 31, 2022 | 207,000.00 |
| Sep 30, 2022 | 1.70 Mn |
| Sep 30, 2022 | 1.70 Mn |
| Jun 30, 2022 | -72,000.00 |
| Jun 30, 2022 | -72,000.00 |
| Mar 31, 2022 | 1.11 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | -861,000.00 |
| Dec 31, 2021 | -861,000.00 |
| Sep 30, 2021 | 1.18 Mn |
| Sep 30, 2021 | 1.18 Mn |
| Jun 30, 2021 | 532,000.00 |
| Jun 30, 2021 | 532,000.00 |
| Mar 31, 2021 | 431,000.00 |
| Mar 31, 2021 | 431,000.00 |
| Dec 31, 2020 | 700,000.00 |
| Dec 31, 2020 | 700,000.00 |
| Sep 30, 2020 | -475,000.00 |
| Sep 30, 2020 | -475,000.00 |